TSE Fundamental Analysis - TRINSEO PLC

Fundamental Rating

Overall TSE gets a fundamental rating of 2 out of 10. We evaluated TSE against 85 industry peers in the Chemicals industry. Both the profitability and financial health of TSE have multiple concerns. While showing a medium growth rate, TSE is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.

In the past year TSE has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.

TSE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

TSE has a Return On Assets of -13.26%. This is in the lower half of the industry: TSE underperforms 76.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROIC	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TSE's Operating Margin has declined in the last couple of years.

With a Gross Margin value of 7.92%, TSE is not doing good in the industry: 84.71% of the companies in the same industry are doing better.

TSE's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for TSE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.92%

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for TSE has been increased compared to 1 year ago.

The number of shares outstanding for TSE has been reduced compared to 5 years ago.

TSE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that TSE is in the distress zone and has some risk of bankruptcy.

TSE has a Altman-Z score of 0.97. This is in the lower half of the industry: TSE underperforms 75.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.97

ROIC/WACCN/A

WACC7.12%

2.3 Liquidity

TSE has a Current Ratio of 1.50. This is a normal value and indicates that TSE is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.50, TSE is doing worse than 65.88% of the companies in the same industry.

A Quick Ratio of 0.95 indicates that TSE may have some problems paying its short term obligations.

With a Quick ratio value of 0.95, TSE is not doing good in the industry: 65.88% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.5
Quick Ratio	0.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TSE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.64%, which is quite good.

The Revenue has decreased by -5.28% in the past year.

The Revenue has been growing slightly by 0.81% on average over the past years.

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

3.2 Future

Based on estimates for the next years, TSE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.67% on average per year.

The Revenue is expected to grow by 4.34% on average over the next years.

EPS Next Y27.34%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue Next Year3.43%

Revenue Next 2Y3.61%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TSE. In the last year negative earnings were reported.

Also next year TSE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

TSE's Enterprise Value to EBITDA is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.51

4.3 Compensation for Growth

A more expensive valuation may be justified as TSE's earnings are expected to grow with 20.67% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.32%

EPS Next 3Y20.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.37%, TSE has a reasonable but not impressive dividend return.

In the last 3 months the price of TSE has falen by -38.41%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.

TSE's Dividend Yield is comparable with the industry average which is at 3.75.

Compared to an average S&P500 Dividend Yield of 2.38, TSE's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	1.37%

5.2 History

The dividend of TSE decreases each year by -50.57%.

TSE has been paying a dividend for at least 10 years, so it has a reliable track record.

Dividend Growth(5Y)-50.57%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

TSE has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-0.45%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

More info and screens

Find the best dividend stocks

Show peers with best dividend

TRINSEO PLC

NYSE:TSE (5/30/2025, 8:04:00 PM)

After market: 3.03 0 (0%)

3.03

+0.11 (+3.77%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)N/A N/A

Inst Owners71.81%

Inst Owner Change1.03%

Ins Owners4.87%

Ins Owner Change24.31%

Market Cap108.02M

Analysts50

Price Target5.61 (85.15%)

Short Float %1.81%

Short Ratio1.72

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.37%

Yearly Dividend0.05

Dividend Growth(5Y)-50.57%

DP-0.45%

Div Incr Years0

Div Non Decr Years0

Ex-Date04-10 2025-04-10 (0.01)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-7.45%

Min EPS beat(2)-15.89%

Max EPS beat(2)0.99%

EPS beat(4)1

Avg EPS beat(4)-9.86%

Min EPS beat(4)-15.89%

Max EPS beat(4)0.99%

EPS beat(8)2

Avg EPS beat(8)-68.87%

EPS beat(12)2

Avg EPS beat(12)-54.58%

EPS beat(16)4

Avg EPS beat(16)-41.48%

Revenue beat(2)0

Avg Revenue beat(2)-7.71%

Min Revenue beat(2)-14.85%

Max Revenue beat(2)-0.57%

Revenue beat(4)0

Avg Revenue beat(4)-5.6%

Min Revenue beat(4)-14.85%

Max Revenue beat(4)-0.57%

Revenue beat(8)1

Avg Revenue beat(8)-5.51%

Revenue beat(12)1

Avg Revenue beat(12)-5.88%

Revenue beat(16)3

Avg Revenue beat(16)-4.16%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0.98%

EPS NY rev (1m)-21.39%

EPS NY rev (3m)-13.51%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.54%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.03
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	13.51

EPS(TTM)-7.12

EYN/A

EPS(NY)-3.49

Fwd EYN/A

FCF(TTM)-3.21

FCFYN/A

OCF(TTM)-1.63

OCFYN/A

SpS95.2

BVpS-19.05

TBVpS-37.15

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.92%
FCFM	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

F-Score4

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	12.76
Cap/Depr	27.98%
Cap/Sales	1.66%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.5
Quick Ratio	0.95
Altman-Z	0.97

F-Score4

WACC7.12%

ROIC/WACCN/A

Cap/Depr(3y)41.39%

Cap/Depr(5y)51.15%

Cap/Sales(3y)2.23%

Cap/Sales(5y)2.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

EPS Next Y27.34%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

Revenue Next Year3.43%

Revenue Next 2Y3.61%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

EBIT growth 1Y77.12%

EBIT growth 3Y-75.28%

EBIT growth 5Y-32.27%

EBIT Next Year793.49%

EBIT Next 3Y136.74%

EBIT Next 5YN/A

FCF growth 1Y-119.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.98%

OCF growth 3YN/A

OCF growth 5YN/A

TRINSEO PLC (TSE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens